| Phase 4 |
| NCT06403943 |
Efficacy Safety BaiDiZiYin ShenQiYiFei Adjunctive Treatments Pulmonary Tuberculosis |
Adjuvant |
Recruiting |
2024-05-08 |
| Phase 3 |
| NCT07268664 |
Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant… |
Rifampicin Resistant Tuberculosis |
Not Yet Recruiting |
2025-12-08 |
| NCT06081361 |
Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin… |
Pulmonary Tuberculosis |
Active, Not Recruiting |
2025-04-01 |
| Phase 2 |
| NCT07372781 |
Clinical Study on the Early Bactericidal Activity of Contezolid Against Mycobacterium… |
Monotherapy |
Enrolling by Invitation |
2026-01-28 |
| NCT06809413 |
Clinical Study on the Early Bactericidal Activity of Sitafloxacin Against Mycobacterium… |
Fluoroquinolone |
Enrolling by Invitation |
2025-02-05 |
| NCT06764368 |
Phase II Study of Adebrelimab, Chemotherapy, and Apatinib for Advanced Pulmonary… |
Neuroendocrine Tumors |
Not Yet Recruiting |
2025-01-08 |
| Phase 1/2 |
| NCT06811012 |
Phase II Clinical Study of Contezolid for the Treatment of Bone and Joint Tuberculosis |
Tuberculosis |
Enrolling by Invitation |
2025-02-06 |
| NCT06811025 |
Phase II Clinical Study of Contezolid for the Treatment of Tuberculous Meningitis |
Tuberculosis |
Enrolling by Invitation |
2025-02-06 |
| Not specified |
| NCT07615309 |
To Evaluate the Clinical Efficacy and Safety of Omadacycline in the Treatment of… |
Mycobacterium Abscessus Infection |
Enrolling by Invitation |
2026-05-29 |
| NCT07607288 |
Collect Data From Patients Receiving Standardized Anti-tuberculosis Therapy, Collect… |
Therapeutic Drug Monitoring (TDM) |
Enrolling by Invitation |
2026-05-26 |